Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
27.10
+0.71 (2.69%)
Aug 4, 2026, 3:00 PM CST
SHA:688399 Market Cap
SHA:688399 has a market cap or net worth of 3.28 billion as of August 4, 2026. Its market cap has decreased by -33.46% in one year.
Market Cap
3.28B
Enterprise Value
2.11B
Revenue
326.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.10
ChartMarket Cap Chart
Since December 5, 2019, SHA:688399's market cap has increased from 3.22B to 3.28B, an increase of 1.83%. That is a compound annual growth rate of 0.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 3.28B | -42.98% |
| Dec 31, 2025 | 5.75B | 54.17% |
| Dec 31, 2024 | 3.73B | 16.52% |
| Dec 29, 2023 | 3.20B | -37.80% |
| Dec 30, 2022 | 5.14B | -36.21% |
| Dec 31, 2021 | 8.06B | -28.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Obio Technology (Group) Corp. | 3.67B |
| Assure Tech (Hangzhou) | 3.57B |
| Pulike Biological Engineering | 3.56B |
| Kexing Biopharm | 3.52B |
| Lifecome Biochemistry | 3.50B |
| Shanghai Shen Lian Biomedical | 3.39B |
| Hinova Pharmaceuticals | 3.28B |
| Baolingbao Biology | 3.05B |